Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

The therapeutic potential of mesenchymal stem cell transplantation as a treatment for multiple sclerosis: consensus report of the International MSCT Study Group.
Disease Modifying Potential of Glatiramer Acetate in Huntington's Disease.
Exploratory analysis of predictors of patient adherence to subcutaneous interferon beta-1a in multiple sclerosis: TRACER study.
Pfizer and Synthon Enter Into U.S. Commercialization Agreement for Potential Generic Treatment of Multiple Sclerosis
It is better to be in a clinical trial than not: lessons learnt from clinical neurology--the management of acute multiple sclerosis relapses.
A practical review of the neuropathology and neuroimaging of multiple sclerosis.
Genzyme’s Lemtrada™ approved in Australia for treatment of multiple sclerosis
Fingolimod and CSF neurofilament light chain levels in relapsing-remitting multiple sclerosis.
Recurrent Nicolau syndrome associated with subcutaneous glatiramer acetate injection-a case report.
Treatment of multiple sclerosis with anti-CD20 antibodies.
[Plasmapheresis in central nervous system disorders].
Cutaneous and pulmonary sarcoidosis following treatment of multiple sclerosis with interferon-beta-1b: a case report.
Serological evidence of increased susceptibility to varicella-zoster virus reactivation or reinfection in natalizumab-treated patients with multiple sclerosis.
2-Methoxyestradiol inhibits experimental autoimmune encephalomyelitis through suppression of immune cell activation.
Anti-Epstein-Barr virus antibodies as serological markers of multiple sclerosis: a prospective study among United States military personnel.
Safety and efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis (FREEDOMS II): a double-blind, randomised, placebo-controlled, phase 3 trial.
Cranial neuropathies in multiple sclerosis defined by magnetic resonance imaging and fludeoxyglucose f 18 positron emission tomography.
Retrospective US database analysis of persistence with glatiramer acetate vs. available disease-modifying therapies for multiple sclerosis: 2001-2010.
Generic Midamor
Clinical and immunological follow-up of B-cell depleting therapy in CNS demyelinating diseases.
Dopaminergic Modulation of CD4+CD25 Regulatory T Lymphocytes in Multiple Sclerosis Patients during Interferon-β Therapy.
Flow cytometric analysis of cerebrospinal fluid samples and its usefulness in routine clinical practice.
Cognitive impairment and cortical degeneration in neuromyelitis optica.
Multiple sclerosis.
Neuroenhancement through cognitive training and anodal tDCS in multiple sclerosis.

Pages